Development and Reform Commission: The output value of the Chinese medicine industry has exceeded 300 billion yuan

Business News Agency April 9th ​​National Development and Reform Commission recently released the “Review of the Economic Operation of the Chinese Medicine Industry in 2010”, which shows that the asset size of the Chinese medicine industry has continued to expand, production and sales have improved significantly, economic benefits have increased significantly, and foreign trade has steadily risen. The industrial output value reached 317.2 billion yuan, a year-on-year increase of 29.5%, and the total realized total profit for the year was nearly 30 billion yuan, an increase of 33% over the same period of last year.

The article stated that with the overall advancement and deepening of the reform of the pharmaceutical and health system, the Chinese medicine manufacturing industry benefited from a favorable policy environment in 2010, and the scale of the industry continued to expand. Product sales revenue, assets, number of companies, and number of employees all appeared in varying degrees. Growth, foreign trade steadily rebounded, and the industry as a whole continued to show good momentum.

Among them, China's TCM manufacturing assets exceeded 300 billion yuan in 2010, an increase of about 18% year-on-year, an increase of nearly 5 percentage points over the same period last year; the number of companies reached more than 2,300, an increase of more than 100 over the same period last year; Nearly 500,000 people, an increase of 7.6% year-on-year; total investment in fixed assets totaled nearly 50 billion yuan, an increase of about 16%.

In 2010, China's Chinese medicine industry achieved an annual industrial output value of 317.2 billion yuan, a year-on-year increase of 29.5%, an increase of 5 percentage points over the same period of the previous year; and annual finished product funds accounted for approximately 20 billion yuan, an increase of approximately 13% over the previous year. At the same time, the output growth rate was 16.5 percentage points lower.

Due to the marked improvement in sales, the total profit of the Chinese medicine industry in China continued to increase last year, with relatively rapid growth, and the loss of loss-making enterprises continued to decline. The industry's accumulated total profit realized in the year was nearly 30 billion yuan, a year-on-year increase of about 33%; the loss was about 16%, which was about 2% lower than the same period of last year; the depth of the loss was about 3%, which was a drop of nearly 1 year-on-year. Percentage.

Last year, China’s total exports of proprietary Chinese medicines totaled 13,910 tons, a year-on-year increase of 4%, a year-on-year increase of 3.2 percentage points over the same period last year; cumulative exports amounted to US$196 million, a year-on-year increase of 18.2%, an increase of 23% over the same period last year. Percentage; export unit price is 14105 US dollars / ton, an increase of 1690 US dollars / ton over the same period the previous year, product added value gradually increased.